BiotechTube
Home/Pipeline/HANDLE Hereditary Cancer NGS Panel

HANDLE Hereditary Cancer NGS Panel

Hereditary Cancer Risk

CommercialNewly launched

Key Facts

Indication
Hereditary Cancer Risk
Phase
Commercial
Status
Newly launched
Company
Amoy Diagnostics

About Amoy Diagnostics

A precision oncology diagnostics company developing PCR and NGS-based companion diagnostic kits for cancer, with a focus on accessibility and global partnerships.

View full company profile

Therapeutic Areas

Oncology

Other Hereditary Cancer Risk Drugs

DrugCompanyPhase
GALEAS Hereditary (UKCA)NonacusApproved
Expedio™ Hereditary Cancer Risk TestingKailos GeneticsCommercial
Cancer Genomics (CGx) TestingPhi Life SciencesCommercial
Hereditary Cancer PanelOxford NanoporeRUO/Clinical Research